IMUGENE LIMITED — Capital/Financing Update 2013

Oct 30, 2013

Appendix(3B( New(issue(announcement(

Rule%2.7,%3.10.3,%3.10.4,%3.10.5

Appendix 3B

New issue announcement, application for quotation of additional securities and agreement

Information%or%documents%not%available%now%must%be%given%to%ASX%as%soon%as%available.%%Information%and% documents%given%to%ASX%become%ASX’s%property%and%may%be%made%public.%

Introduced!01/07/96!!Origin:!Appendix!5!!Amended!01/07/98,!01/09/99,!01/07/00,!30/09/01,!11/03/02,!01/01/03,!24/10/05,!01/08/12!

Name!of!entity!

Imugene!Limited!

ABN!

99 009 179 551

We!(the!entity)!give!ASX!the!following!information.!

Part 1 - All issues

You%must%complete%the%relevant%sections%(attach%sheets%if%there%is%not%enough%space).

1! +Class!of!+securities!issued!or!to! Ordinary!Fully!Paid!Shares! be!issued! 2! Number!!of![+] securities!issued!or! a) 85,000,000' to! be! issued! (if! known)! or! b) '''2,400,000' maximum! number! which! may! be!issued! 3! Principal! terms! of! the! Ordinary!Fully!Paid!Shares! +securities! (eg,! if! options,! exercise!price!and!expiry!date;!if! partly! paid! +securities,! the! amount! outstanding! and! due! dates! for! payment;! if! +convertible! securities,! the! conversion! price! and! dates! for! conversion)!

+!See!chapter!19!for!defined!terms.!

Appendix!3B!!Page!1!

01/08/2012!

Appendix(3B( New(issue(announcement(

4 Do the +securities rank equally in all respects from the date of allotmentwithanexisting+class ofquoted+securities? If the additional securities do notrankequally,pleasestate: • thedatefromwhichtheydo • the extent to which they participate for the next dividend, (in the case of a trust, distribution) or interestpayment • the extent to which they do not rank equally, other than in relation to the next dividend, distribution or interestpayment 5 Issuepriceorconsideration 6 Purposeoftheissue (If issued as consideration for theacquisitionofassets,clearly identifythoseassets) 6a Is the entity an +eligible entity that has obtained security holderapprovalunderrule7.1A? IfYes,completesections6b–6h in relation to the +securities the subjectofthisAppendix3B,and complywithsection6i 6b The date the security holder resolution under rule 7.1A was passed 6c Number of +securities issued withoutsecurityholderapproval underrule7.1	Yes
	$0.01pershare
	a) Private placement. The proceeds from the placement will primarily be used to assist in the funding of the Company after the proposed acquisition of BioLife Science Qld Limited, for working capital purposes and to advance Imugene’s Linguet technology. b) Issued as consideration for fees payable.
	Yes
	30November2012
	50,147,385

+!See!chapter!19!for!defined!terms.!

Appendix!3B!Page!2!

01/08/2012!

Appendix(3B( New(issue(announcement(

6d Number of +securities issued with security holder approval underrule7.1A 6e Number of +securities issued with security holder approval under rule 7.3, or another specificsecurityholderapproval (specifydateofmeeting) 6f Number of securities issued underanexceptioninrule7.2 6g If securities issued under rule 7.1A,wasissuepriceatleast75% of 15 day VWAP as calculated under rule 7.1A.3? Include the issue date and both values. IncludethesourceoftheVWAP calculation. 6h If securities were issued under rule 7.1A for non`cash consideration, state date on which valuation of consideration was released to ASXMarketAnnouncements 6i Calculatetheentity’sremaining issuecapacityunderrule7.1and rule7.1A–completeAnnexure1 and release to ASX Market Announcements 7 Dates of entering +securities into uncertificated holdings or despatchofcertificates 8 Number and +class of all +securities quoted on ASX (including the securities in section2ifapplicable)	37,252,615	37,252,615
	Nil
	Nil
	Yes VWAP30/09/13to18/10/13(15tradingdays that trades were recorded prior to date agreementwasmade):$0.00974 Source:Imugene
	N/A
	SeeAnnexure1.
	30October2013
	Number	+Class
	465,562,516	Ordinary Full Paid Shares

+!See!chapter!19!for!defined!terms.!

Appendix!3B!!Page!3!

01/08/2012!

Appendix(3B( New(issue(announcement(

Number! +Class! 9! Number! and! +class! of! all! +securities! not! quoted! on! ASX! 50,000,000! Unlisted!Options!(IMUAK)! ( including the! securities! in! Exercise!Price:!$0.02! section!2!if!applicable)! Expiry!Date:!31!December!2015!!! 10! Dividend!policy!(in!the!case!of!a! Unchanged! trust,!distribution!policy)!on!the! increased!capital!(interests)!

Part 2 - Bonus issue or pro rata issue

11 Is security holder approval required? 12 Istheissuerenounceableornon` renounceable? 13 Ratio in which the +securities willbeoffered 14 +Classof+securitiestowhichthe offerrelates 15 +Record date to determine entitlements 16 Will holdings on different registers (or subregisters) be aggregated for calculating entitlements? 17 Policy for deciding entitlements inrelationtofractions 18 Namesofcountriesinwhichthe entity has +security holders who will not be sent new issue documents Note:Securityholdersmustbetoldhowtheir entitlementsaretobedealtwith. Crossreference:rule7.7.	N/A
	N/A
	N/A
	N/A
	N/A
	N/A
	N/A
	N/A

+!See!chapter!19!for!defined!terms.!

Appendix!3B!Page!4!

01/08/2012!

Appendix(3B( New(issue(announcement(

19 Closing date for receipt of acceptancesorrenunciations 20 Namesofanyunderwriters 21 Amountofanyunderwritingfee orcommission 22 Names of any brokers to the issue 23 Fee or commission payable to thebrokertotheissue 24 Amount of any handling fee payable to brokers who lodge acceptances or renunciations on behalfof+securityholders 25 If the issue is contingent on +security holders’ approval, the dateofthemeeting 26 Dateentitlementandacceptance form and prospectus or Product DisclosureStatementwillbesent topersonsentitled 27 If the entity has issued options, and the terms entitle option holders to participate on exercise, the date on which notices will be sent to option holders 28 Daterightstradingwillbegin(if applicable) 29 Date rights trading will end (if applicable) 30 How do +security holders sell theirentitlements_infull_through abroker? 31 How do +security holders sell part of their entitlements	N/A
	N/A
	N/A
	N/A
	N/A
	N/A
	N/A
	N/A
	N/A
	N/A
	N/A
	N/A
	N/A

+!See!chapter!19!for!defined!terms.!

Appendix!3B!!Page!5!

01/08/2012!

Appendix(3B( New(issue(announcement(

through! a! broker! and! accept! for! the!balance?!

32! How!do![+] security!holders!dispose! N/A! of! their! entitlements! (except! by! sale!through!a!broker)?!

33! +Despatch!date!

N/A!

Part 3 - Quotation of securities

You%need%only%complete%this%section%if%you%are%applying%for%quotation%of%securities%

• 34! Type!of!securities!! ( tick%one )!

• (a)! ! Shares!described!in!Part!1!

• (b)! All!other!securities!

Example:! restricted! securities! at! the! end! of! the! escrowed! period,! partly! paid! securities! that! become! fully! paid,! employee!incentive!share!securities!when!restriction!ends,!securities!issued!on!expiry!or!conversion!of!convertible! securities!

Entities that have ticked box 34(a)

Additional(securities(forming(a(new(class(of(securities(

Tick%to%indicate%you%are%providing%the%information%or% documents

35! If!the![+] securities!are![+] equity!securities,!the!names!of!the!20!largest!holders!of!the! additional![+] securities,!and!the!number!and!percentage!of!additional![+] securities! held!by!those!holders!

36! If!the![+] securities!are![+] equity!securities,!a!distribution!schedule!of!the!additional! +securities!setting!out!the!number!of!holders!in!the!categories!

1!!1,000! 1,001!!5,000! 5,001!!10,000! 10,001!!100,000! 100,001!and!over!

• 37! A!copy!of!any!trust!deed!for!the!additional![+] securities!

+!See!chapter!19!for!defined!terms.!

Appendix!3B!Page!6!

01/08/2012!

Appendix(3B( New(issue(announcement(

Entities that have ticked box 34(b)

• 38! Number! of! securities! for! which! +quotation!is!sought!

39! Class! of! +securities! for! which! quotation!is!sought!

40! Do!the![+] securities!rank!equally!in! all! respects! from! the! date! of! allotment! with! an! existing![+] class! of!quoted![+] securities?!

• If!the!additional!securities!do!not! rank!equally,!please!state:! • the!date!from!which!they!do! • the! extent! to! which! they! participate! for! the! next! dividend,! (in! the! case! of! a! trust,! distribution)! or! interest! payment!

• • the! extent! to! which! they! do! not!rank!equally,!other!than!in! relation! to! the! next! dividend,! distribution! or! interest! payment!

41! Reason! for! request! for! quotation! now!! Example:!In!the!case!of!restricted!securities,!end! of!restriction!period!

(if! issued! upon! conversion! of! another! security,! clearly! identify! that!other!security)!

Number! +Class!

42! Number! and! +class! of! all! +securities! quoted! on! ASX! ( including !the!securities!in!clause! 38)!!

+!See!chapter!19!for!defined!terms.!

Appendix!3B!!Page!7!

01/08/2012!

Appendix(3B( New(issue(announcement(

Quotation(agreement(

• 1! +Quotation!of!our!additional! +securities!is!in!ASX’s!absolute!discretion.!!ASX! may!quote!the![+] securities!on!any!conditions!it!decides.!!!

• 2! We!warrant!the!following!to!ASX.!

• The!issue!of!the![+] securities!to!be!quoted!complies!with!the!law!and!is! not!for!an!illegal!purpose.!

• There! is! no! reason! why! those![+] securities! should! not! be! granted! +quotation.!

• An!offer!of!the![+] securities!for!sale!within!12!months!after!their!issue! will!not!require!disclosure!under!section!707(3)!or!section!1012C(6)!of! the!Corporations!Act.!

Note:!An!entity!may!need!to!obtain!appropriate!warranties!from!subscribers!for!the!securities!in!order!to!be! able!to!give!this!warranty!

• Section!724!or!section!1016E!of!the!Corporations!Act!does!not!apply!to! any! applications! received! by! us! in! relation! to! any![+] securities! to! be! quoted!and!that!no`one!has!any!right!to!return!any![+] securities!to!be! quoted!under!sections!737,!738!or!1016F!of!the!Corporations!Act!at!the! time!that!we!request!that!the![+] securities!be!quoted.!

• If!we!are!a!trust,!we!warrant!that!no!person!has!the!right!to!return!the! +securities!to!be!quoted!under!section!1019B!of!the!Corporations!Act!at! the!time!that!we!request!that!the![+] securities!be!quoted.!

• 3! We!will!indemnify!ASX!to!the!fullest!extent!permitted!by!law!in!respect!of!any! claim,! action! or! expense! arising! from! or! connected! with! any! breach! of! the! warranties!in!this!agreement.!

• 4! We!give!ASX!the!information!and!documents!required!by!this!form.!!If!any! information! or! document! not! available! now,! will! give! it! to! ASX! before! +quotation!of!the! +securities!begins.!!We!acknowledge!that!ASX!is!relying!on! the!information!and!documents.!!We!warrant!that!they!are!(will!be)!true!and! complete.!

Sign!here:!! !!!!!!!!!!!!!!!!!!!!!!!Date:!31!October!2013! (Company!Secretary)!

Print!name:!! Justyn!Stedwell!

==> picture [37 x 23] intentionally omitted <==

The CFO Solution

+!See!chapter!19!for!defined!terms.!

Appendix!3B!Page!8!

01/08/2012!

Appendix(3B( New(issue(announcement(

==!==!==!==!==!

Appendix 3B – Annexure 1

Calculation of placement capacity under rule 7.1 and rule 7.1A for[+] eligible entities

Introduced!01/08/12!

Part 1

Rule 7.1 – Issues exceeding 15% of capital

Step 1: Calculate “A”, the base figure from which the placement capacity is calculated

Part 1	Part 1
Rule 7.1 – Issues exceeding 15% of capital
Step 1: Calculate “A”, the base figure from which the placement capacity is calculated
Insertnumber of fully paid ordinary securities on issue 12 months before date of issue or agreement to issue	338,637,220
Addthe following: • Number of fully paid ordinary securities issued in that 12 month period under an exception in rule 7.2 • Number of fully paid ordinary securities issued in that 12 month period with shareholder approval • Number of partly paid ordinary securities that became fully paid in that 12 month period Note: • Include only ordinary securities here – other classes of equity securities cannot be added • Include here (if applicable) the securities the subject of the Appendix 3B to which this form is annexed • It may be useful to set out issues of securities on different dates as separate line items	33,888,932
Subtractthe number of fully paid ordinary securities cancelled during that 12 month period
“A”	372,526,152

+!See!chapter!19!for!defined!terms.!

Appendix!3B!Page!9!

01/08/2012!

Appendix(3B( New(issue(announcement(

Appendix3B Newissueannouncement	Appendix3B Newissueannouncement
Step 2: Calculate 15% of “A”
“B”	0.15 [Note: this value cannot be changed]
Multiply“A” by 0.15	55,878,922
Step 3: Calculate “C”, the amount of placement capacity under rule 7.1 that has already been used
Insertnumber of equity securities issued or agreed to be issued in that 12 month period not counting_those issued: • Under an exception in rule 7.2 • Under rule 7.1A • With security holder approval under rule 7.1 or rule 7.4 _Note: • This applies to equity securities, unless specifically excluded – not just ordinary securities • Include here (if applicable ) the securities the subject of the Appendix 3B to which this form is annexed • It may be useful to set out issues of securities on different dates as separate line items	55,783,749
“C”	55,783,749
Step 4: Subtract “C” from [“A” x “B”] to calculate remaining placement capacity under rule 7.1
“A” x 0.15 Note: number must be same as shown in Step 2	55,878,922
Subtract“C” Note: number must be same as shown in Step 3	55,783,749
Total[“A” x 0.15] – “C”	95,173 [Note: this is the remaining placement capacity under rule 7.1]

+!See!chapter!19!for!defined!terms.!

Appendix!3B!Page!10!

01/08/2012!

Appendix(3B( New(issue(announcement(

Part 2

Rule 7.1A – Additional placement capacity for eligible entities

Step 1: Calculate “A”, the base figure from which the placement capacity is calculated

372,526,152 “A” Note: number must be same as shown in Step 1 of Part 1 Step 2: Calculate 10% of “A” “D” 0.10 Note: this value cannot be changed Multiply “A” by 0.10 37,252,615

Step 3: Calculate “E”, the amount of placement capacity under rule 7.1A that has already been used

Insert number of equity securities issued or 37,252,615 agreed to be issued in that 12 month period under rule 7.1A Notes: • This applies to equity securities – not just ordinary securities • Include here – if applicable – the securities the subject of the Appendix 3B to which this form is annexed • Do not include equity securities issued under rule 7.1 (they must be dealt with in Part 1), or for which specific security holder approval has been obtained • It may be useful to set out issues of securities on different dates as separate line items “E” 37,252,615

+!See!chapter!19!for!defined!terms.!

Appendix!3B!Page!11!

01/08/2012!

Appendix(3B( New(issue(announcement(

Step 4: Subtract “E” from [“A” x “D”] to calculate remaining placement capacity under rule 7.1A

Appendix3B Newissueannouncement	Appendix3B Newissueannouncement
Step 4: Subtract “E” from [“A” x “D”] to calculate remaining placement capacity under rule 7.1A
“A” x 0.10 Note: number must be same as shown in Step 2	37,252,615
Subtract“E” Note: number must be same as shown in Step 3	37,252,615
Total[“A” x 0.10] – “E”	Nil Note: this is the remaining placement capacity under rule 7.1A

+!See!chapter!19!for!defined!terms.!

Appendix!3B!Page!12!

01/08/2012!

==> picture [164 x 49] intentionally omitted <==

ASX ANNOUNCEMENT (ASX Code: IMU)

NOTICE UNDER SECTION 708A(5) OF THE CORPORATIONS ACT

Thursday 31 October 2013

This notice is given under paragraph (5)(e) of section 708A of the Corporations Act.

The Following securities of the Company were issued without disclosure to investors under Part 6D.2 of the Corporations Act:

Type:	Ordinary Shares
Class/Description:	Ordinary Fully Paid
ASX Code:	IMU
Date of Issue:	30 October 2013
Number Issued:	87,400,000

As at the date of this notice, the Company has complied with:

a) The provisions of Chapter 2M of the Corporations Act as they apply to the Company; and

• b) Section 674 of the Corporations Act.

Other information which is excluded information required to be disclosed under None paragraph 708A (7) & 708A(8) of the Corporations Act

For and on behalf of Imugene Limited;

==> picture [80 x 59] intentionally omitted <==

Phillip Hains CFO & Company Secretary

Imugene!Limited! !!ABN!99!009!179!551!

Phone:!!!!!!+!61!(0)3!9824!5254! Facsimile:!+!61!(0)3!9822!7735!

Suite!1,!1233!High!Street! Armadale,!Victoria! Australia!!3143

www.imugene.com!